Research Reveals Hidden Failure Modes of Large Language Models in Scientific Decision-Making

The deployment of large language models in data-constrained environments could lead to significant errors in scientific research, affecting outcomes and decisions.

• Publication: On March 16, 2026, Nazia Riasat released a paper on arXiv detailing the failure modes of large language models in gene prioritization tasks.
• Findings: The study revealed that despite high stability, models like Claude Opus 4.5 hallucinated invalid gene identifiers, while others showed significant divergence from statistical ground truth.
• Implications: The research calls for rigorous validation processes beyond mere stability checks to ensure the reliability of LLM outputs in scientific workflows.

• LLMs in Bioinformatics: Large language models have become increasingly integrated into bioinformatics, particularly for tasks like gene prioritization from RNA-seq data.
• Assumptions of Stability: Previous evaluations emphasized stability and reproducibility, assuming these metrics guaranteed reliability in outputs.
• Critical Risks: In scenarios where data is limited, such as differential expression analysis, stability alone can mask significant inaccuracies, leading to erroneous conclusions.

The research paper "When Stability Fails: Hidden Failure Modes Of LLMs in Data-Constrained Scientific Decision-Making" by Nazia Riasat introduces a crucial evaluation framework for large language models (LLMs). The study specifically examines how these models perform in gene prioritization tasks derived from RNA-seq data, a common practice in bioinformatics. The findings challenge the prevailing notion that stability across multiple runs is a sufficient indicator of reliability.

Riasat's study evaluated three prominent models—GPT-5.2, Gemini 3, and Claude Opus 4.5—using a fixed dataset from the Gene Expression Omnibus (GEO: GSE239514). The models were tested under various prompt conditions, including strict and relaxed false discovery rates (FDR). Despite demonstrating near-perfect stability, the models exhibited alarming discrepancies from the statistical ground truth. For instance, Claude Opus 4.5, while showing a stability score close to 1.00, produced outputs that included an average of 20 invalid gene identifiers per run, highlighting a significant gap between stability and correctness.

The study underscores the importance of prompt sensitivity, revealing that slight variations in the wording of prompts can lead to substantial differences in output accuracy. For example, the Jaccard similarity index—a measure of similarity between sample sets—dropped to 0.00 for Claude Opus 4.5, indicating a complete failure to align with the ground truth despite its high stability. In contrast, Gemini 3 showed a Jaccard divergence of 0.08, suggesting that even minor adjustments in prompts can lead to varying degrees of accuracy.

These findings have critical implications for the deployment of LLMs in scientific workflows, particularly in fields where data is scarce and correctness is paramount. The paper advocates for a shift in focus from merely assessing stability to implementing explicit ground-truth validation processes. This approach is essential to mitigate the risks associated with deploying LLMs in data-constrained environments, where the stakes for accuracy are high.

As the scientific community increasingly turns to LLMs for insights, the need for robust validation mechanisms becomes more pressing. The study aligns with broader concerns about reproducibility in scientific research, emphasizing that reliance on LLMs without rigorous checks could lead to significant errors in data interpretation and decision-making.

• Researchers in Bioinformatics: They will need to reassess their reliance on LLMs for gene prioritization tasks.
• Data Scientists: Those developing or deploying LLMs in scientific contexts will face increased scrutiny regarding validation practices.
• Healthcare Professionals: They may experience the consequences of inaccurate scientific outputs in clinical settings, impacting patient care decisions.

• Validation Practices: Watch for shifts in validation protocols within scientific research that prioritize ground-truth checks over stability metrics. This could reshape how LLMs are integrated into workflows.
• Model Updates: Monitor updates from LLM developers regarding improvements in accuracy and reliability, particularly in bioinformatics applications. These changes may influence adoption rates in scientific communities.
• Community Discussions: Follow discussions in scientific forums and workshops on the implications of LLM findings, as they could lead to new standards in research methodologies.